Cagrilintide is an investigational amylin-receptor agonist studied for its potential roles in satiety signaling, metabolic regulation, and feeding-behavior research
This mechanism of action is responsible for the reduction of the lipid deposits in the blood vessels, which may diminish the risk of atherosclerosis
Die richtige Verwendung und Dosierung des Wirkstoffs ist entscheidend, um reproduzierbare und valide Forschungsergebnisse zu gewhrleisten
[DOI] [PubMed] [Google Scholar] 75.Strinic D., Belosic Halle Z., Luetic K., Nedic A., Petrovic I., Sucic M., Zivanovic Posilovic G., Balenovic D., Strbe S., Udovicic M., et al
Here, we reported that a protein-protein interaction between dopamine D2 receptor (D2R) and dopamine transporter (DAT) provides a new way to modulate the activities of DAT and dopamine reuptake